U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07260370) titled 'The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy' on Nov. 21.
Brief Summary: Among the currently important biomarkers, circulating tumor cells and microRNA (miRNA) have received significant attention. The latter, also translated as micro-ribonucleic acid, is a widely present ribonucleic acid (RNA) molecule in eukaryotes, approximately 21 to 23 nucleotides in length, which regulates the expression of other genes. miRNAs originate from RNAs that are transcribed from DNA but cannot be further translated into proteins (classified as non-coding RNA). miRNAs bind to target messenger R...